Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses & Two

Updated 05/24/2024

Status Completed

Clinical Trial Summary

An investigational multi-purpose solution (MPS)was clinically evaluated against Biotrue MPS at specific time points over the course of four days. The study was conducted with PureVision lenses.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Corneal Staining

Clinical Trial Details

NCT number	NCT01240122
Study type	Interventional
Source	Abbott Medical Optics
Contact
Status	Completed
Phase	N/A
Start date	August 2010
Completion date	November 2010

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02251561` - Clinical Evaluation of Opti-Free III (FID 109182) Compared to Opti-Free Plus® in Japan	N/A
	Completed	`NCT01100424` - Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining	N/A
	Recruiting	`NCT05626478` - Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery	Phase 4
	Recruiting	`NCT00381446` - Evaluation of Corneal Staining With Various Contact Lens/Solution Combinations	N/A
	Completed	`NCT01335750` - A Clinical Comparison of Marketed Lens Care Solutions With Avaira Lens Brand	N/A
	Completed	`NCT00518700` - Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients	Phase 4
	Completed	`NCT00483795` - Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining	Phase 4